LICORbio
NE - LincolnBiotechnology
Focus: LICORbio is a biotechnology company specializing in cell imaging technology focused on oncology applications. The company operates at a small scale with minimal public financial disclosure.
Profile data last refreshed 15h ago · AI intelligence enriched 1w ago
Open Jobs
4
Should You Work at LICORbio?
AI assessmentLICORbio is a speculative early-stage play best suited for risk-tolerant scientists seeking hands-on R&D roles in an unproven oncology imaging platform.
Why Work Here
- Early-stage oncology biotech with focused cell imaging specialty offers hands-on involvement in technology development and clinical translation
- Small team size (4 active job openings) suggests flat hierarchy and direct impact on company direction
Data completeness
1/9 — Limited
Company HealthSolid
Pipeline
Early-stage
0 total
LOE Risk
Protected
No near-term cliffs
Hiring
Stable
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Help build intelligence for LICORbio
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.